• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Mentor Texas ARTOURA Breast Tissue Expander; Expander, skin, inflatable

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Mentor Texas ARTOURA Breast Tissue Expander; Expander, skin, inflatable Back to Search Results
Catalog Number TEXP140RH
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Post Operative Wound Infection (2446)
Date of Event 01/01/2016
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that a patient underwent breast reconstruction with two 600cc artoura breast tissue expanders.Post-operatively, the patient suffered bilateral breast infection.As a result, the patient underwent breast implant removal and replacement surgery on (b)(6)2026.The replacement devices were two mentor gel implants.This medwatch form is for the right breast prosthesis.
 
Additional Manufacturer Narrative
Since the device has not been returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors can be made.As such, the investigation will be closed.If the complaint device is received in the future, the investigation will be reopened and conducted as appropriate.A manufacturing record evaluation (mre) was performed, and no anomalies were found related to this complaint.In addition, the mre verifies that the device was manufactured in accordance with documented specification and procedures.Reason for device explant and/or reoperation: infection.Mentor is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which mentor has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, mentor, or its employees that the report constitutes an admission that the device, mentor, or its employees caused or contributed to the potential event described in this report.If certain information is unknown, not available or does not apply, the section/field of the form is left blank.Manufacturer¿s reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARTOURA Breast Tissue Expander
Common Device Name
Expander, skin, inflatable
Manufacturer (Section D)
Mentor Texas
3041 skyway circle north
irving TX 75038
Manufacturer (Section G)
Mentor Texas
3041 skyway circle north
irving TX 75038
Manufacturer Contact
henry boden
3041 skyway circle north
irving, TX 75038
+1(949)788-2078
MDR Report Key50078092
Report Number1645337-2026-08555
Device Sequence Number16015819
Product Code LCJ
UDI-Device Identifier00081317009498
UDI-Public(01)00081317009498(17)190925(10)6980144
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
K150777
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Device Explanted Year2016
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Type of Report Initial
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/25/2019
Device Catalogue NumberTEXP140RH
Device Lot Number6980144
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Received by Manufacturer 07/09/2026
Initial Report FDA Received Date07/30/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured10/07/2015
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexFemale
Patient RaceWhite
-
-